FTC Risks Help Push Metsera Back To Pfizer
By Bryan Koenig · November 10, 2025, 4:52 PM EST
Novo Nordisk AS' aspirations to pry Metsera away from Pfizer Inc. collapsed over the weekend under the pressure of a revised Pfizer offer, twin court challenges and "a call from the...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login